Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without it

The objective of the study is to assess the scope and timing of tuberculosis vaccination in children with perinatal exposure to HIV, to determine the effectiveness of vaccination by the scarsize and results of Mantoux test in 12 month safter vaccination.Subjects and methods. Documents on vaccination...

Full description

Bibliographic Details
Main Authors: V. A. Kukarkina, A. A. Golubkova, A. S. Podymova, A. A. Kukarkina
Format: Article
Language:Russian
Published: New Terra Publishing House 2020-10-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1462
_version_ 1826563046207651840
author V. A. Kukarkina
A. A. Golubkova
A. S. Podymova
A. A. Kukarkina
author_facet V. A. Kukarkina
A. A. Golubkova
A. S. Podymova
A. A. Kukarkina
author_sort V. A. Kukarkina
collection DOAJ
description The objective of the study is to assess the scope and timing of tuberculosis vaccination in children with perinatal exposure to HIV, to determine the effectiveness of vaccination by the scarsize and results of Mantoux test in 12 month safter vaccination.Subjects and methods. Documents on vaccination (Form no.063/u) and case histories (Form no.112/u) of 216 children with perinatal exposure to HIV were analyzed. The control group consisted of 100 children of the same age group born by HIV negative mothers. In this study, epidemiological (descriptive-evaluative, andanalytical) and statistical methods of research were applied.Results. The proportion of children vaccinated against tuberculosis in the maternity ward in the group with perinatal exposure to HIV made 74/196, and in the control group – 82/99, pχ2 < 0.01. The main reasons for the lack of vaccination were the failure to undergo the three-stage preventive chemotherapy of perinatal HIV infection (35%), neonatal pathology and prematurity (42%). No difference was found in the frequency of the vaccination scar formation and results of Mantoux test (in 12 months after vaccination) in children exposed to HIV and children from the control group (p > 0.05).65.3% of children exposed to HIV developed the vaccination scar and demonstrated post-vaccination allergies (55.3%) in 12 months after vaccination and there was no difference from children of the control group.
first_indexed 2024-03-12T04:57:40Z
format Article
id doaj.art-5e74420f38ec41faa5b8a85c9185efe2
institution Directory Open Access Journal
issn 2075-1230
2542-1506
language Russian
last_indexed 2025-03-14T09:57:44Z
publishDate 2020-10-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj.art-5e74420f38ec41faa5b8a85c9185efe22025-03-02T11:22:32ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062020-10-01989394210.21292/2075-1230-2020-98-9-39-421460Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without itV. A. Kukarkina0A. A. Golubkova1A. S. Podymova2A. A. Kukarkina3Regional Center for AIDS Prevention and Control; Ural State Medical UniversityCentral Research Institute of Epidemiology, RospotrebnadzorRegional Center for AIDS Prevention and ControlChildren Municipal Clinical Hospital no. 11The objective of the study is to assess the scope and timing of tuberculosis vaccination in children with perinatal exposure to HIV, to determine the effectiveness of vaccination by the scarsize and results of Mantoux test in 12 month safter vaccination.Subjects and methods. Documents on vaccination (Form no.063/u) and case histories (Form no.112/u) of 216 children with perinatal exposure to HIV were analyzed. The control group consisted of 100 children of the same age group born by HIV negative mothers. In this study, epidemiological (descriptive-evaluative, andanalytical) and statistical methods of research were applied.Results. The proportion of children vaccinated against tuberculosis in the maternity ward in the group with perinatal exposure to HIV made 74/196, and in the control group – 82/99, pχ2 < 0.01. The main reasons for the lack of vaccination were the failure to undergo the three-stage preventive chemotherapy of perinatal HIV infection (35%), neonatal pathology and prematurity (42%). No difference was found in the frequency of the vaccination scar formation and results of Mantoux test (in 12 months after vaccination) in children exposed to HIV and children from the control group (p > 0.05).65.3% of children exposed to HIV developed the vaccination scar and demonstrated post-vaccination allergies (55.3%) in 12 months after vaccination and there was no difference from children of the control group.https://www.tibl-journal.com/jour/article/view/1462children exposed to hivbcg vaccinationefficacy
spellingShingle V. A. Kukarkina
A. A. Golubkova
A. S. Podymova
A. A. Kukarkina
Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without it
Туберкулез и болезни лёгких
children exposed to hiv
bcg vaccination
efficacy
title Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without it
title_full Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without it
title_fullStr Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without it
title_full_unstemmed Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without it
title_short Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without it
title_sort comparative assessment of tuberculosis vaccination in children with perinatal exposure to hiv and without it
topic children exposed to hiv
bcg vaccination
efficacy
url https://www.tibl-journal.com/jour/article/view/1462
work_keys_str_mv AT vakukarkina comparativeassessmentoftuberculosisvaccinationinchildrenwithperinatalexposuretohivandwithoutit
AT aagolubkova comparativeassessmentoftuberculosisvaccinationinchildrenwithperinatalexposuretohivandwithoutit
AT aspodymova comparativeassessmentoftuberculosisvaccinationinchildrenwithperinatalexposuretohivandwithoutit
AT aakukarkina comparativeassessmentoftuberculosisvaccinationinchildrenwithperinatalexposuretohivandwithoutit